Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
Active, not recruiting · NCT05475366 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures | Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, microphthalmia, syndromic 9, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Not applicable | 2026-10-01 | NCT05475366 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut Curie | 48 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Robert Debré | Reims | France | 1 |
| Hôpital Beaujon | Clichy | France | 2 |
| Hôpital Claude Hurriez | Lille | France | 1 |
| Hôpital Henri Mondor | Créteil | France | 13 |
| Hôpital PAUL BROUSSE 12 Avenue Paul Vaillant Couturier | Villejuif | France | 1 |
| Institut Curie | Saint-Cloud | France | 19 |
| Institut Paoli-Calmettes | Marseille | France | 1 |